Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition

Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 – 18:13 Source link

Pfizer CEO Bourla scored big raise in 2021—to $24M—as drugmaker played a leading pandemic role

Pfizer CEO Bourla scored big raise in 2021—to $24M—as drugmaker played a leading pandemic role esagonowsky Fri, 03/18/2022 – 14:40 Source link

After Pfizer's pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission

After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 – 11:16 Source link

Pfizer's deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid

Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid kdunleavy Fri, 03/18/2022 – 09:33 Source link

Fierce Pharma Asia—Eisai's reduced Aduhelm role; Chinese biotechs' US delisting risks; Zai Lab's new COO from Lilly

Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lilly aliu Fri, 03/18/2022 – 06:28 Source link

Amid sales slump, Teva CEO Schultz's pay falls 7% to $14.7M

Amid sales slump, Teva CEO Schultz’s pay falls 7% to $14.7M kdunleavy Thu, 03/17/2022 – 19:38 Source link

Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriq

Merck details Keytruda’s postsurgery lung cancer win, teeing up fight against Roche’s Tecentriq aliu Thu, 03/17/2022 – 11:52 Source link

Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots

Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots kdunleavy Thu, 03/17/2022 – 11:32 Source link

Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months

Ahead of Humira’s patent cliff, AbbVie’s Rinvoq notches third new use in 4 months kdunleavy Thu, 03/17/2022 – 09:44 Source link

Biogen's Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch

Biogen’s Tecfidera patent contingency plan falls flat amid sputtering Aduhelm launch fkansteiner Thu, 03/17/2022 – 09:13 Source link

After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl

After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl aliu Thu, 03/17/2022 – 08:53 Source link

Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class

Bristol Myers’ Opdivo aide Opdualag scores FDA approval in melanoma, opens 3rd immune checkpoint drug class aliu Thu, 03/17/2022 – 06:26 Source link